Global Legionella Testing Market Insights Forecasts to 2032
- The Global Legionella Testing Market Size was valued at USD 292.40 Million in 2022.
- The Market Size is Growing at a CAGR of 7.8% from 2022 to 2032
- The Worldwide Legionella Testing Market Size testing Market Size is expected to reach USD 619.68 Million by 2032
- Asia-Pacific is expected To Grow higher during the forecast period
Get more details on this report -
The Global Legionella Testing Market Size is expected to reach USD 619.68 Million by 2032, at a CAGR of 7.8% during the forecast period 2022 to 2032.
Legionella testing is a critical process used to detect the presence of legionella bacteria in water systems, particularly in buildings and cooling towers. Legionella can cause severe respiratory infections, such as legionnaires' disease, posing significant health risks to occupants. The testing involves collecting water samples and analyzing them for legionella bacteria using various methods, including culture-based techniques and polymerase chain reaction (PCR) assays. Monitoring the presence of legionella is crucial for preventing outbreaks and ensuring the safety of individuals who may come into contact with contaminated water sources. Regular testing and maintenance of water systems are essential to mitigate the risk of legionella proliferation and protect public health.
This research report categorizes the market for legionella testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the legionella testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the legionella testing market.
Global Legionella Testing Market Report Coverage
|Market Size in 2022:||USD 292.40 Million|
|Forecast Period 2022-2032 CAGR:||7.8%|
|2032 Value Projection:||USD 619.68 Million|
|Historical Data for:||2018-2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||110|
|Segments covered:||By Test Type, By Application, By End-User, By Region, and COVID-19 Impact Analysis.|
|Companies Covered:||Quidel Corporation, ChemREADY, Abbott Laboratories, Merck KGaA, Phigenics LLC, IDEXX Corporation, Bio-Rad Laboratories, Aquacert Ltd., Qiagen NV, BioMerieux SA, Thermo Fisher Scientific Inc., and Other Key Venders.|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
The legionella testing market is experiencing significant growth due to various drivers that are shaping its expansion. One of the primary drivers is the increasing awareness and concern regarding legionnaires' disease and other waterborne infections caused by legionella bacteria. As governments and healthcare organizations emphasize public health, the demand for legionella testing has surged, leading to market growth. The growing number of outbreaks and reported cases of Legionnaires' disease is another crucial driver. These incidents have prompted industries, commercial buildings, and healthcare facilities to prioritize legionella testing as part of their risk management and safety protocols. This increased focus on preventive measures to avoid outbreaks has further fueled the market's expansion. Moreover, strict regulations and guidelines implemented by regulatory authorities have compelled various sectors to conduct regular legionella testing. Compliance with these standards ensures that industries and public places maintain safe water systems, minimizing the risk of legionella contamination and potential outbreaks. Advancements in testing technologies have also played a significant role in driving market growth. The development of rapid and accurate testing methods, such as PCR-based assays and nucleic acid testing, has streamlined the detection process, enabling early identification of legionella bacteria and efficient preventive measures. Additionally, the rising adoption of automated testing solutions has improved testing efficiency and reduced turnaround time, further contributing to market expansion. These automated systems offer reliable and high-throughput testing capabilities, making them attractive options for large-scale testing requirements in various industries. Overall, the combination of increasing awareness, stringent regulations, technological advancements, and the growing number of reported cases has fueled the demand for legionella testing, propelling the market's growth prospects.
The legionella testing market also faces certain restraints that can hinder its growth. One of the main challenges is the high cost associated with advanced testing methods and equipment, which may limit their adoption, particularly for smaller facilities and organizations with budget constraints. Additionally, the complexity of testing procedures and the need for skilled personnel can pose barriers to widespread implementation. Moreover, in some regions, there might be a lack of awareness about legionella-related risks and the importance of testing, leading to a slower uptake of testing services.
- In 2022, the PCR segment accounted for around 37.5% market share
On the basis of the test type, the global legionella testing market is segmented into culture media, urine antigen testing, PCR, and direct fluorescent antibody. The PCR (Polymerase Chain Reaction) category has secured the largest market share in the Legionella testing market due to its numerous advantages. PCR offers rapid and highly sensitive detection of Legionella bacteria in water samples, enabling early identification and timely preventive measures. Its ability to amplify and detect specific DNA sequences of Legionella with high accuracy has made it a preferred choice in laboratories and healthcare settings. Additionally, advancements in PCR technologies have further enhanced its efficiency and reliability, contributing to its dominant position in the market for legionella testing.
- The water testing segment held the largest market over the forecast period
Based on the application, the global legionella testing market is segmented into water testing and IVD testing. The water testing segment has dominated the legionella testing market over the forecast period due to its paramount importance in detecting legionella bacteria in water systems. As Legionella primarily spreads through contaminated water sources, the demand for water testing services has significantly increased across industries, healthcare facilities, and public places. Stricter water safety regulations and the rising awareness of Legionnaires' disease have further bolstered the adoption of water testing for Legionella detection. As a result, the water testing segment has held the largest market share during the forecast period, addressing the critical need for ensuring safe water systems.
- The diagnostic labs segment held the largest market in 2022, revenue share of around 41.5%.
Based on the end-user, the global legionella testing market is segmented into hospitals & clinics, diagnostic labs, and water treatment industries. The diagnostic labs segment has emerged as the largest market in the field of Legionella testing due to several key factors. Diagnostic labs specialize in conducting a wide range of tests, including Legionella testing, and are equipped with advanced technologies and skilled personnel, ensuring accurate and reliable results. These labs cater to various industries, healthcare facilities, and commercial buildings, making them a crucial part of Legionella risk management strategies. Additionally, their ability to handle a large volume of samples efficiently and offer quick turnaround times has further contributed to their dominant position in the Legionella testing market.
Regional Segment Analysis of the Legionella Testing Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 42.3% revenue share in 2022.
Get more details on this report -
Based on region, North America has emerged as the largest market for legionella testing due to increase in reported cases of legionnaires' disease, prompting a heightened focus on preventive measures and regular testing. North America has stringent regulations and guidelines governing water quality and safety, driving the demand for legionella testing to comply with these standards. Additionally, the region's well-established healthcare and industrial sectors prioritize regular testing in their facilities to ensure the safety of occupants and workers.
Europe has secured the second-largest revenue share due to a rising number of legionella-related outbreaks and infections, driving the demand for testing services. Additionally, Europe's robust healthcare infrastructure and strict water safety regulations have compelled industries and facilities to conduct regular legionella testing to ensure compliance and safeguard public health.
- In August 2022, Genomadix Inc., a Canadian firm, announced a deal with Mayo Clinic to improve its point-of-care portable PCR-based diagnostics device, CubeTM, which provides results in about an hour.
- In December 2022, The South Carolina Department of Health and Environmental Control revealed that Legionnaire's disease cases in Darlington County had been examined. So far, 13 instances of the illness have been discovered as part of the epidemic.
The report offers the appropriate analysis of the key organizations/companies involved within the global legionella testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Quidel Corporation
- Abbott Laboratories
- Merck KGaA
- Phigenics LLC
- IDEXX Corporation
- Bio-Rad Laboratories
- Aquacert Ltd.
- Qiagen NV
- BioMerieux SA
- Thermo Fisher Scientific Inc.
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global legionella testing market based on the below-mentioned segments:
Legionella Testing Market, By Test Type
- Culture Media
- Urine Antigen Testing
- Direct Fluorescent Antibody
Legionella Testing Market, By Application
- Water Testing
- IVD Testing
Legionella Testing Market, By End-User
- Hospitals & Clinics
- Diagnostic Labs
- Water Treatment Industries
Legionella Testing Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?